BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//eventon.com NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:69ea526ae6997
DTSTAMP:20260423T171002Z
DTSTART:20260110T223100Z
DTEND:20270303T223100Z
LOCATION:
SUMMARY:Laboratory Testing for Detecting Xa-Inhibitory DOAC
DESCRIPTION:Direct oral anticoagulants (DOACs)\,  such as apixaban and riva
 roxaban\,  arrived on the market with no need for monitoring. As the use of
  DOACs expand\,  it is becoming clearer that their measurement may be neces
 sary in specific situations\,  and more institutions are integrating either
  qualitative or quantitative assays. To help you[..]\nhttps://www.captodayo
 nline.com/events/laboratory-testing-for-detecting-xa-inhibitory-doac/
URL:https://www.captodayonline.com/events/laboratory-testing-for-detecting-xa-inhibitory-doac/
END:VEVENT
END:VCALENDAR